Filana Therapeutics
FLNA
64 hedge funds and large institutions have $44.7M invested in Filana Therapeutics in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 28 reducing their positions, and 8 closing their positions.
3% less funds holding
Funds holding: 66 → 64 (-2)
8% less capital invested
Capital invested by funds: $48.4M → $44.7M (-$3.72M)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
61% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$877K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$114K |
| 3 |
State Street
Boston,
Massachusetts
|
+$82.7K |
| 4 |
Renaissance Technologies
New York
|
+$66.1K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$40.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$235K |
| 2 |
Millennium Management
New York
|
-$189K |
| 3 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
-$187K |
| 4 |
Morgan Stanley
New York
|
-$173K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$150K |
FLNA Hedge Fund Activity: Q1 2015 in Review
64 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q1 2015, worth a combined $44.7M — down 7.7% from $48.4M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of FLNA and 7 opened new positions — a net loss of 1 holder — while 28 trimmed existing stakes and 11 added.
The largest buyer was Nantahala Capital Management, adding an estimated $877K. The largest seller was Bridgeway Capital Management, cutting an estimated $235K.
- 64 institutional investors held Filana Therapeutics (FLNA) as of Q1 2015, down from 66 in Q4 2014.
- Funds reported $44.7M of Filana Therapeutics stock for Q1 2015, down 7.7% quarter-over-quarter.
- 7 funds opened new Filana Therapeutics positions in Q1 2015 and 8 closed out, a net change of -1 holder.
- The largest Filana Therapeutics buyer in Q1 2015 was Nantahala Capital Management, an estimated $877K added.
- The largest Filana Therapeutics seller in Q1 2015 was Bridgeway Capital Management, an estimated $235K sold.
Based on aggregated 13F filings for Q1 2015.